Mercedes Rodríguez Garrote

How healthy are clones and their progeny: 5 years of field experience

M. Panarace, Jaume Agüero, Mercedes Rodríguez Garrote et al. · Theriogenology · 2006 · 171 citations

Biology, Reproductive Success, Genetic Testing +9

Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study

Peter Langhorne, Martin O’Donnell, Siu Lim Chin et al. · The Lancet · 2018 · 132 citations · Full text

Stroke Rehabilitation, Medicine, Different Economic Levels +11

Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study

Jean–Luc Van Laethem, Ivan Borbath, Hans Prenen et al. · The Lancet Oncology · 2024 · 37 citations · Full text

Oncology, Pancreatic Cancer, Medicine +7

Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC)

Guillem Argilés, N. Mulet Margalef, Manuel Valladares‐Ayerbes et al. · Annals of Oncology · 2019 · 19 citations · Full text

Gastrointestinal Oncology, Medicine, Clinical Trials +10

Sequential <i>nab</i>-paclitaxel/gemcitabine followed by modified FOLFOX for first-line metastatic pancreatic cancer: The SEQUENCE trial.

Alfredo Carrato, Roberto Pazo-Cid, Teresa Macarulla et al. · Journal of Clinical Oncology · 2022 · 17 citations

Sequence Trial, Oncology, Modified Folfox +15